The Role of Sodium-Glucose Cotransporter-2 Inhibitors in the Treatment Paradigm of CKD in Africa: An African Association of Nephrology Panel Position Paper

Affiliations

• ¹ Nephrology Department and Research Laboratory LR19ES11, Faculty of Medicine, Sfax University, Sfax, Tunisia.
• ² Nephrology Department, Dalal Jamm Hospital, Cheikh Anta Diop University, Dakar, Senegal.
• ³ Department of Internal Medicine and Nephrology, M.P Shah Hospital, Nairobi, Kenya.
• ⁴ Department of Medicine, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
• ⁵ Renal Unit, Directorate of Medicine, Komfo Anokye Teaching Hospital, Kumasi, Ghana.
• ⁶ Renal Unit, Internal Medicine Department, University of Kinshasa, the Democratic Republic of Congo.
• ⁷ Nephrology Unit, SSR National Hospital, Pamplemousses, Mauritius.
• ⁸ Division of Nephrology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
• ⁹ Renal Unit, Department of Internal Medicine School of Medicine, College of Health Sciences Addis Ababa University, Addis Ababa, Ethiopia.
• ¹⁰ Department of Internal Medicine and Specialties, Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Yaoundé, Cameroon.
• ¹¹ Renal Unit, Department of Medicine, College of Medicine, University of Nigeria, Ituku-Ozalla, Enugu Nigeria.
• ¹² Renal Unit, Department of Internal Medicine, Alex Ekwueme Federal University Teaching Hospital Abakaliki, Nigeria.
• ¹³ Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
• ¹⁴ Department of Medicine, Cairo University, Giza, Egypt; Egyptian Society of Nephrology and Transplantation; African Association of Nephrology (AFRAN), Arab Board of Nephrology; MESOT; Councilor DICG.
• ¹⁵ Department of Nephrology and Internal Medicine, University Hospital of Treichville, Felix Houphouet-Boigny University, Abidjan, Côte d'Ivoire.